Shiavax J. Rao/X
Oct 3, 2026, 05:32
Shiavax J. Rao: PERT 2026 Session Explores Long-Term Anticoagulation and DOAC Management
Shiavax J. Rao, Trainee Council Chair and Trainee Council Member at The PERT Consortium, Cardiology Fellow at Guthrie, shared The PERT Consortium’s post on X:
“An amazing, engaging and very insightful session at PERT 2026 covering long-term anticoagulation,
DOAC de-escalation, periprocedural guidance, addressing non-adherence, transitions of care and population-based DOAC management.”
The PERT Consortium shared a post on X:
“A huge thank you to our amazing panel of experts for an insightful discussion on anticoagulation in PE!
So many important takeaways, thought-provoking questions, and opportunities to improve clinical practice.”

Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments